• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明边缘变性的角膜交联:五年后的评估

Corneal Cross-Linking in Pellucid Marginal Degeneration: Evaluation after Five Years.

作者信息

Irajpour Matin, Noorshargh Pegah, Peyman Alireza

机构信息

Isfahan Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Curr Ophthalmol. 2022 Jul 26;34(2):229-233. doi: 10.4103/joco.joco_16_22. eCollection 2022 Apr-Jun.

DOI:10.4103/joco.joco_16_22
PMID:36147277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9487015/
Abstract

PURPOSE

To evaluate the long-term outcome of corneal cross-linking (CXL) for pellucid marginal degeneration (PMD).

METHODS

In a retrospective study, forty eyes of forty patients were enrolled. All subjects had undergone CXL for PMD at least 5 years before the assessments. Visual acuity, refraction, and topography data were compared to their respective values before CXL.

RESULTS

The comparison between mean preoperative logMAR uncorrected visual acuity and 5-year postoperative evaluation revealed no significant change (1.20 ± 0.65 and 1.17 ± 0.64, > 0.05). No statistically significant difference was noted comparing preoperative mean logMAR best-corrected visual acuity (BCVA) and postoperative mean logMAR BCVA (0.24 ± 0.19 and 0.22 ± 0.20, > 0.05). We did not find any significant difference between pre- and postoperative spherical equivalent and spherical refractive errors ( = 0.419 and = 0.396, respectively). Regarding the BCVA Snellen lines, 23 eyes had no significant change in pre- and postoperative examinations, 11 eyes had improvement, and 6 subjects showed worsening defined as significant when two or more lines change. The spherical equivalent refractive error improved in 4 subjects, was stable in 25, and worsened in 11 subjects, while a 0.5 diopter or more myopic change was considered significant. Furthermore, regarding steep keratometry values, 25 subjects were stable, 7 had improvements, and 8 worsened.

CONCLUSION

CXL appears to be a safe and effective procedure to halt the progression of PMD.

摘要

目的

评估角膜交联术(CXL)治疗透明边缘变性(PMD)的长期疗效。

方法

在一项回顾性研究中,纳入了40例患者的40只眼。所有受试者在评估前至少5年接受了CXL治疗PMD。将视力、验光和地形图数据与其在CXL术前的各自值进行比较。

结果

术前平均logMAR未矫正视力与术后5年评估结果的比较显示无显著变化(分别为1.20±0.65和1.17±0.64,P>0.05)。术前平均logMAR最佳矫正视力(BCVA)与术后平均logMAR BCVA比较,未发现统计学上的显著差异(分别为0.24±0.19和0.22±0.20,P>0.05)。我们未发现术前和术后等效球镜度及球镜屈光不正之间有任何显著差异(分别为P=0.419和P=0.396)。关于BCVA Snellen视力表行数,23只眼在术前和术后检查中无显著变化,11只眼有改善,6只眼视力下降,当两行或更多行变化时被定义为显著下降。等效球镜屈光不正4例改善,25例稳定,11例恶化,而近视变化0.5屈光度或更多被认为是显著的。此外,关于陡峭角膜曲率值,25例稳定,7例改善,8例恶化。

结论

CXL似乎是一种安全有效的阻止PMD进展的手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c7/9487015/3bc0bc0f4a88/JCO-34-229-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c7/9487015/3bc0bc0f4a88/JCO-34-229-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c7/9487015/3bc0bc0f4a88/JCO-34-229-g001.jpg

相似文献

1
Corneal Cross-Linking in Pellucid Marginal Degeneration: Evaluation after Five Years.透明边缘变性的角膜交联:五年后的评估
J Curr Ophthalmol. 2022 Jul 26;34(2):229-233. doi: 10.4103/joco.joco_16_22. eCollection 2022 Apr-Jun.
2
Corneal collagen cross-linking: a review of 1-year outcomes.角膜胶原交联:1年随访结果综述
Eye Contact Lens. 2014 Nov;40(6):345-52. doi: 10.1097/ICL.0000000000000094.
3
Refractive and corneal aberrometric changes after intracorneal ring implantation in corneas with pellucid marginal degeneration.透明边缘变性角膜行角膜内环植入术后的屈光及角膜像差变化
Ophthalmology. 2009 Sep;116(9):1656-64. doi: 10.1016/j.ophtha.2009.06.002. Epub 2009 Jul 29.
4
Full-Ring Intracorneal Implantation in Corneas With Pellucid Marginal Degeneration.全环角膜内植入术治疗透明边缘变性角膜
Iran Red Crescent Med J. 2015 Dec 26;17(12):e28974. doi: 10.5812/ircmj.28974. eCollection 2015 Dec.
5
Long-Term Comparison of Simultaneous Topography-Guided Photorefractive Keratectomy Followed by Corneal Cross-linking versus Corneal Cross-linking Alone. topography-guided 准分子激光角膜切削术联合角膜交联术与单纯角膜交联术的长期疗效比较
Ophthalmology. 2016 May;123(5):974-83. doi: 10.1016/j.ophtha.2016.01.010. Epub 2016 Feb 17.
6
Non-topography-guided PRK combined with CXL for the correction of refractive errors in patients with early stage keratoconus.非地形图引导的准分子原位角膜磨镶术联合角膜交联术治疗早期圆锥角膜患者的屈光不正
J Refract Surg. 2014 Oct;30(10):688-93. doi: 10.3928/1081597X-20140903-02.
7
Short-term result of collagen crosslinking in pellucid marginal degeneration.透明边缘变性中胶原交联的短期结果
Adv Biomed Res. 2016 Dec 27;5:194. doi: 10.4103/2277-9175.192732. eCollection 2016.
8
Corneal Collagen Cross-Linking in Pellucid Marginal Degeneration: 2 Patients, 4 Eyes.透明边缘变性中的角膜胶原交联:2例患者,4只眼。
Case Rep Ophthalmol Med. 2015;2015:840687. doi: 10.1155/2015/840687. Epub 2015 May 11.
9
Photorefractive keratectomy followed by cross-linking versus cross-linking alone for management of progressive keratoconus: two-year follow-up.光折射性角膜切削术联合交联术与单纯交联术治疗进展性圆锥角膜:两年随访。
Am J Ophthalmol. 2013 Jan;155(1):54-65.e1. doi: 10.1016/j.ajo.2012.07.004. Epub 2012 Sep 27.
10
Accelerated corneal collagen cross-linking for progressive keratoconus.加速角膜胶原交联治疗进行性圆锥角膜
Cutan Ocul Toxicol. 2014 Jun;33(2):168-71. doi: 10.3109/15569527.2013.816724. Epub 2013 Jul 23.

引用本文的文献

1
Pellucid Marginal Degeneration: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies.透明边缘变性:病理生理学、诊断及管理策略的全面综述
J Clin Med. 2025 Jul 22;14(15):5178. doi: 10.3390/jcm14155178.
2
A sequential approach to the management of an advanced case of pellucid marginal degeneration.一种针对透明边缘变性晚期病例的序贯管理方法。
Am J Ophthalmol Case Rep. 2023 Nov 23;32:101966. doi: 10.1016/j.ajoc.2023.101966. eCollection 2023 Dec.

本文引用的文献

1
Pellucid marginal degeneration versus keratoconus: distinction with wide-field SD-OCT corneal sublayer pachymetry.透明边缘变性与圆锥角膜:通过超广角SD-OCT角膜亚层测厚法进行鉴别
Br J Ophthalmol. 2021 Dec;105(12):1638-1644. doi: 10.1136/bjophthalmol-2020-316496. Epub 2020 Oct 14.
2
Late progressive corneal flattening, haze and visual loss after eccentric crosslinking for Pellucid marginal degeneration.透明边缘变性行偏心交联术后的晚期进行性角膜扁平、混浊及视力丧失
Am J Ophthalmol Case Rep. 2020 Feb 22;18:100621. doi: 10.1016/j.ajoc.2020.100621. eCollection 2020 Jun.
3
Corneal Cross-Linking: An Effective Treatment Option for Pellucid Marginal Degeneration.
角膜交联术:透明边缘变性的一种有效治疗选择
Semin Ophthalmol. 2019;34(7-8):512-517. doi: 10.1080/08820538.2019.1659832. Epub 2019 Aug 26.
4
Corneal crosslinking for pellucid marginal degeneration.角膜交联术治疗板层状角膜营养不良。
J Cataract Refract Surg. 2019 Aug;45(8):1163-1167. doi: 10.1016/j.jcrs.2019.03.018. Epub 2019 Jul 2.
5
Transepithelial Phototherapeutic Keratectomy Followed by Corneal Collagen Crosslinking for the Treatment of Pellucid Marginal Degeneration: Long-term Results.经上皮光角膜切削术联合角膜胶原交联治疗后发性边缘性角膜变性:长期结果。
Cornea. 2019 Aug;38(8):980-985. doi: 10.1097/ICO.0000000000002003.
6
Corneal crosslinking in a case with Axenfeld-Rieger syndrome and unilateral pellucid marginal degeneration.Axenfeld-Rieger综合征合并单侧透明边缘变性病例的角膜交联术
Ther Adv Ophthalmol. 2019 Jan 18;11:2515841418822288. doi: 10.1177/2515841418822288. eCollection 2019 Jan-Dec.
7
Pellucid marginal degeneration: Detection, discrimination from other corneal ectatic disorders and progression.先天性边缘性角膜营养不良:检测、与其他角膜扩张性疾病的鉴别诊断及进展。
Cont Lens Anterior Eye. 2019 Aug;42(4):341-349. doi: 10.1016/j.clae.2018.11.010. Epub 2018 Nov 22.
8
Corneal hysteresis and corneal resistance factor in pellucid marginal degeneration.透明边缘变性中的角膜滞后和角膜阻力因子。
J Curr Ophthalmol. 2017 Aug 18;30(1):42-47. doi: 10.1016/j.joco.2017.08.002. eCollection 2018 Mar.
9
Crab claw pattern on corneal topography: pellucid marginal degeneration or inferior keratoconus?角膜地形图的蟹爪样改变:明胶边缘性变性还是下方角膜圆锥?
Eye (Lond). 2018 Jan;32(1):11-18. doi: 10.1038/eye.2017.198. Epub 2017 Sep 22.
10
[Results of corneal crosslinking for pellucid marginal corneal degeneration].
Vestn Oftalmol. 2017;133(3):58-66. doi: 10.17116/oftalma2017133358-64.